1. Home
  2. EFR vs CERS Comparison

EFR vs CERS Comparison

Compare EFR & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Senior Floating-Rate Fund of Beneficial Interest

EFR

Eaton Vance Senior Floating-Rate Fund of Beneficial Interest

N/A

Current Price

$10.65

Market Cap

333.9M

Sector

Finance

ML Signal

N/A

Logo Cerus Corporation

CERS

Cerus Corporation

N/A

Current Price

$2.56

Market Cap

276.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
EFR
CERS
Founded
N/A
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
EDP Services
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
333.9M
276.0M
IPO Year
2003
1996

Fundamental Metrics

Financial Performance
Metric
EFR
CERS
Price
$10.65
$2.56
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
108.6K
1.1M
Earning Date
01-01-0001
04-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
47.62
EPS
N/A
N/A
Revenue
N/A
$51,326,000.00
Revenue This Year
N/A
$25.31
Revenue Next Year
N/A
$9.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
30.68
52 Week Low
$10.40
$1.12
52 Week High
$12.88
$2.96

Technical Indicators

Market Signals
Indicator
EFR
CERS
Relative Strength Index (RSI) 20.34 58.68
Support Level N/A $1.99
Resistance Level $11.20 $2.96
Average True Range (ATR) 0.08 0.15
MACD -0.03 0.02
Stochastic Oscillator 5.66 84.35

Price Performance

Historical Comparison
EFR
CERS

About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest

Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: